Japan Autoimmune Disease Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics), By Product (Instruments and Consumables and Assays) By Test Type (Antinuclear antibody tests, Autoantibody tests, C-reactive Protein (CRP), Complete blood count (CBC), Urinalysis and Others), By End Use (Hospitals, Diagnostic Centres and Others) and Japan Autoimmune Disease Diagnostics Market Insights, Industry Trend, Forecasts to 2035

Japan Autoimmune Disease Diagnostics Market Insights Forecasts to 2035

• The Japan Autoimmune Disease Diagnostics Market Size Was Estimated at USD 365.8 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 6.53% from 2025 to 2035
• The Japan Autoimmune Disease Diagnostics Market Size is Expected to Reach USD 733.8 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The Japan Autoimmune Disease Diagnostics Market Size is anticipated to Reach USD 733.8 Million by 2035, Growing at a CAGR of 6.53% from 2025 to 2035. The Japan autoimmune disease diagnostics market is driven by various factors such as rising incidence of autoimmune disorders such as type 1 diabetes in newborn babies, rising demand for rapid diagnostics, expanding lab automation rates, technological advancements and rising research for the development of new diagnostic tools.

Market Overview

The Autoimmune disease diagnostics are the methods or procedures used to detect and diagnose autoimmune diseases, which occur when the bodys immune system mistakenly attacks its own healthy tissues. The diagnosis is essential for early detection and effective treatment planning for autoimmune diseases such as rheumatoid arthritis, type 1 diabetes, and multiple sclerosis. The common autoimmune diseases include obesity, CVD, and all cancers. The Japanese autoimmune disease diagnostics market is experiencing rapid growth due to the rise in the aging population in Japan. The genetic factors, environmental exposure, particular hormones, and vulnerability to specific infections are the major reasons for the increasing incidence of autoimmune disorders. A rising pace of new emerging technologies and the resultant generation of laboratory automation technologies also play a major role in market growth. This trend is driven by increased utilization of advanced technology by doctors that allows them to perform a vast range of tests with speedier and more precise results. The discovery of novel biomarkers is a prominent opportunity in this market. The development of personalized testing based on individual genetic makeup with the help of AI and ML is another opportunity in this market.

Report Coverage

This research report categorizes the market for the Japan autoimmune disease diagnostics market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan autoimmune disease diagnostics market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan autoimmune disease diagnostics market.

Driving Factors

The Japan autoimmune disease diagnostics market is experiencing rapid growth due to various factors. The rising awareness about autoimmune disease among people is the main driving factor for this market. The technological advancements and lab automation are anticipated to boost the market growth. Clinicals are adopting advanced technologies to conduct tests with faster and more accurate results. The rise in diseases like RA, type 1 diabetes leads to the growing clinical demand, which drives the growth of this market.

Restraining Factors

The expansion of the autoimmune disease diagnostics market in Japan is being held back by certain key obstacles. The strict regulations about this market may delay the approval of new diagnostic products. The cost and time for the development process impact the profitability of the companies operating in this market.

Market Segmentation

The Japan autoimmune disease diagnostics market share is classified into type, product, and test type.

• The localized segment held the dominant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan autoimmune disease diagnostics market is segmented by type into systemic autoimmune disease diagnostics and localized autoimmune disease diagnostics. Among these, the localized segment held the dominant share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to increased autoimmune disease prevalence, diagnostic advancements, rising awareness, technological innovations and research.

• The consumables & assays accounted for the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan autoimmune disease diagnostics market is segmented by product into instruments and consumables and assays. Among these, the consumables & assays segment accounted for the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. this is due to every laboratory diagnostics test utilizes these kits, reagents and antibodies. Advancement in consumable technologies gives cost cost-effective alternative to traditional diagnostic instruments, which drives the growth of this segment.

• The antinuclear antibody test segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan autoimmune disease diagnostics market is segmented by test type into antinuclear antibody tests, autoantibody tests, c-reactive protein (CRP), complete blood count (CBC), urinalysis and others. Among these, the antinuclear antibody test segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to the rising applications of antinuclear antibody tests in the diagnosis of various autoimmune diseases. The method demonstrated high sensitivity and accuracy.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations or companies involved within the Japan autoimmune disease diagnostics market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Siemens Healthineers AG
• Abbott Laboratories
• Fisher Diagonstics K.K
• F.Hoffmann-La Roche Ltd.
• Sysmex Corporation
• Bio-Rad laboratories K.K.
• Otsuka Pharmaceutical Co., Ltd
• Others

Recent Developments

• In August 2024, Otsuka Pharmaceutical Co., Ltd, acquired Jnana Therapeutics to expand Speciality and Autoimmune Portfolios and Drug Discovery Technologies.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan autoimmune disease diagnostics market based on the below-mentioned segments:

Japan Autoimmune Disease Diagnostics Market, By Type

• Systemic autoimmune disease diagnostics
• Localized autoimmune disease diagnostics

Japan Autoimmune Disease Diagnostics Market, By Product

• Instruments
• Consumables and Assays

Japan Autoimmune Disease Diagnostics Market, By Test Type

• Antinuclear antibody tests
• Autoantibody tests
• C-reactive Protein (CRP)
• Complete blood count (CBC)
• Urinalysis
• Others

Japan Autoimmune Disease Diagnostics Market, By End Use

• Hospitals
• Diagnostic centres
• Others